This compound is a macrolide derivative used as a reference standard for the identification and quantification of the impurity designated as Clarithromycin EP Impurity P in pharmaceutical quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 123967-58-8
Clarithromycin
pharmaceutical raw material
PUBCHEM_71315393
pharmaceutical intermediate
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-((4-Dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy)-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
pharmaceutical intermediate
N-Desmethyl Clarithromycin
pharmaceutical raw material
Acetamidine hydrochloride
pharmaceutical intermediate
Methanesulfonyl chloride
pharmaceutical intermediate
(3aR,4R,5R,6aS)-5-(tert-butyldimethylsilyloxy)-4-((R,E)-3-(tert-butyldimethylsilyloxy)-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one
pharmaceutical intermediate
1-AMINO-4,4-DIFLUOROCYCLOHEXANECARBOXYLIC ACID
pharmaceutical intermediate
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2R,4R,5S,6S)-4,5-dimethoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
GABUBURUMNNRLM-AUALEGHESA-N
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)OC)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O